Ranitidine

  • 20 x 150 mg tablets
  • 20 x 300 mg tablets
Indications:
  • Short-term treatment and maintenance therapy for active duodenal ulcer.
  • The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome).
  • Short-term treatment of active, benign gastric ulcer.
  • Maintenance therapy for gastric ulcer.
  • Treatment of Gastroesophageal Reflux Disease (GERD).
  • Treatment and maintenance of erosive esophagitis.
 
For additional information about this product, contact our Medical Department:
dmedica@pharmabrand.com.ec